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Abstvuct-Previous studies have suggested that NO may play an important role m protecting the renal vessels from anglotensm II (ANGII)-mediated vasoconstrrction One possible mechanism for this mteraction is that ANGII could stimulate NO production m the kidney by increasing endothehal NO synthase (NOS III) The present studies were performed m rats to determine whether acute or chrome elevations m ANGII are associated with enhanced renal NOS III mRNA or protem synthesis In both acute and chronic studies captopril (20 pg/kg/mm) was given IV to mhibit endogenous ANGII production Acute suprarenal mfusion of ANGII (8 rig/kg/mm) for 110 mmutes had no effect on arterial pressure but decreased GFR and renal plasma flow by 20% and 30%, respectively, and increased renal vascular resistance by 70% Acute ANGII Increased renal NOS III mRNA by 70% (as determined by ribonuclease protection assay), but had no effect on renal NOS III protein concentration (as detected by Western blot analyses) In contrast, chrome mfuslon of ANGII (5 rig/kg/mm) for 10 days, increased arterial pressure by 30% and tended to reduce GFR and renal plasma flow Chrome ANGII had no effect on renal NOS III mRNA levels, but increased NOS III protein by 90% These data suggest that ANGII can stimulate NOS III synthesis and suggest that this may be one of the mechamsms whereby AngII may enhance NO production (Hypertension. 1998; 31[part 2]:283-288.) Key Words: GFR n renal hemodynamics n mRNA w nbonuclease protection assay n Western blot I n recent years there has been considerable interest in the mteraction between NO and angiotensm II (ANGII) '*' While ANGII is known to play an important role m controlling renal hemodynamics via its actions on postglomerular vessels, recent studies have implied that ANGII may have an effect on preglomerular vessels that is modulated by the effects of mtnc oxide (NO) or prostaglandms Ito and colleagues, using isolated rabbit arterioles, demonstrated that production of NO is more important in modulation of afferent artenolar tone rather than having an effect on the efferent arteriole 3 These investigators further found that NO modulated ANGIIinduced vasoconstncnon of the afferent arteriole but not the efferent arteriole 4 We have also recently reported that the acute effect of ANGII on preglomerular vessels m dogs is importantly modulated by mtnc oxide 5 These data suggested that NO may play an important protective role m modulatmg the vasoconstnctor effect of ANGII on preglomerular vessels
The mechanisms by whrch NO could protect the renal vasculature from vasoconstnctor ANGII have not been fully elucidated One possible mechanism is that ANGII could enhance NO production and NO would offset a direct vasoconstrictor effect of ANGII Whether ANGII is capable of stimulatmg renal NO production is unclear Deng and colleagues found that acute infusion of pressor doses of ANGII increased urinary mtrate/mtnte excretion, metabolites of NO and indicators of NO production 6 However, chronic ANGII (5-6 days) had no effect on nitrate/mtnte excretion 6 Although this study suggests a role for ANGII m stimulatmg NO smce unnary mtrate/mtnte excretion estnnates whole body NO production, it is unclear whether ANGII stimulates renal NO production m these studies There are at least two mechanisms by which ANGII could increase renal NO production First, ANGII could increase mtnc oxide synthase enzyme activity by causing an increase in intracellular calcium concentration Studies have been performed which document that ANGII is capable of mcreasmg intracellular calcium m a concentration-dependent manner m endothehal cells in culture '*' Secondly, ANGII could increase NO by mcreasmg endothehal NO synthase (NOS III) synthesis, either on a transcriptional level, typically by mcreasmg and/or stabilizing the mRNA levels for NOS III, or on a translational level, and could thereby increase the amount of NOS III protein Both transcriptional and translational mcreases in NOS III would increase NO production, if it IS assumed that an increase m NOS III protein would be translated mto an increase m NOS III activity m the cell and if the levels of substrate argmme and cofactors are not ratelimiting A direct effect of ANGII on NOS III synthesis has not been previously mvestigated, however
The present studies were performed to determine if acute mtrarenal nonpressor doses of ANGII could stimulate NOS III synthesis In addition, pressor doses of ANGII were given chronically for 10 days to determine the long-term effect of ANGII on transcription and translation of NOS III Renal hemodynamlcs were measured m 6 control rats and 8 ANGII-treated rats) Specifically, rats were anesthetized by mtrapentoneal mJectlon of the tluobarbmuate, Inactm (100 to 110 mg/kg body weight, RBI) and placed on a temperature-regulated surgery table to mamtam rectal temperature at 36 to 38°C Femoral and Jugular catheters were placed, and a tracheostomy was performed as described previously X" A catheter (PE-10) was also mserted below the blfurcatlon of the aorta on the left and advanced above the renal artenes for suprarenal infusion of lsotomc saline or ANGII A 23g needle connected to PE-50 tubing was inserted mto the left renal vem m the retrograde chrectmn for blood samphng for determmatlon of extraction across the kidney for calculation of renal plasma flow Dunng catheter placement, the rats received an mfuslon of lsoncotlc artificial rat plasma (2 5g/dL bovine Immunoglobulm, 2 5g/dL bovine serum albumin m Ringer's solution) at 12 5 ml/kg/h for 45 mmutes and thereafter at 1 5 ml/kg/h throughout the experimental penod to mamtam an euvolemic preparation '"" 3H-muhn (15 to 20 /Kl/ml salme, New England Nuclear), was mfused at 1 5 mL/h As shown m Fig lA, In protocol 2, 20 rats (9 control and 12 Angll-treated)
were studied, and hemodynamics were measured in all rats received captopnl (20 pg/kg/mm) IV throughout the control (4 days) and the experimental periods (10 days) Rats m group 2 (n=12) received captopnl during the control penod (4 days) and captoprd and ANGII (5 rig/kg/mm) m the expenmental period (10 days) Abdomma1 aorttc and femoral venous catheters were implanted mto rats under pentobarbital (50 mg/kg) anesthesia A mldhne abdominal mclSion was made and the abdommal aorta was separated from the mfenor vena cava A small hole was made m the aorta with a 20g needle and a catheter of medical vinyl tubing (sz V/4, BOLAB) m the shape of an "s" was inserted mto the aorta The femoral vem was also cannulated with vinyl tubing (sz V/3, BOLAB)
Both catheters were advanced subcutaneously along the back and extenonzed at the nape of the neck through a button sutured to the skm and connected to a sprmg Rats were placed mto mdlvidual metabohsm cages, and the spnng tether was connected to a two-channel hydraulic swivel above the cage The femoral catheter was connected via the swivel to an mfusion pump at a rate of 0 62 mL/h The arterial catheter was connected via the swivel to a transducer (Cobe) connected to an A-D converter for 24-hour blood pressure recording Rats were provided with normal sodium Intake (2 2 mEq/d) via the combmatmn of diet and saline mfuslon As shown m Fig IB, 
Acute Response to ANGII
As shown m Table 1 , there were no changes m mean artenal pressure, GFR, renal plasma flow (RPF), or renal vascular resistance wlthm group 1 (control) rats Suprarenal mfuslon of ANGII (group 2 rats) had no effect on mean arterial pressure, but caused GFR to decrease by 20% RPF also decreased by 30% with ANGII, and renal vascular resistance mcreased by 70% Renal NOS III mRNA was increased by 74% with acute suprarenal mfuslon of ANGII (Fig 2A) In contrast, there was no change m renal NOS III protein concentration m response to ANGII (Rg 2B) Response to Chronic ANGII As shown m Table 2 , there was no effect of time on mean arterial pressure, GFR or RPF (group 1) In response to chronic ANGII mfuslon, mean arterial pressure increased by approximately 30% (group 2) There was a tendency for GFR and RPF to decrease, but not slgmficantly so Chronic mfuslon of pressor doses of ANGII for 10 days had no effect on renal NOS III mRNA levels (Fig 3A) , but did increase NOS III protein m the kidney by 90% (Fig 3B) Discussion The present studies demonstrate that acute ANGII-induced reductions m renal hemodynamlcs are associated with mcreased renal NOS III mRNA production
In addition, we report that long-ten-n elevations m ANGII result m increased NOS III protein synthesis, supportmg the hypothesis that ANGII can chronically increase NO production m the kidney Acute ANGII mfuslons at nonpressor doses caused a reduction m GFR and renal plasma flow In addition, ANGII increased the renal mRNA levels of NOS III However, there was no effect on renal NOS III protem concentrations The lack of an acute effect of ANGII to increase renal NOS III protein 1s not surpnsmg since the ANGII infusion time was only 110 minutes and was probably not long enough to allow translation of NOS III protein to be upregulated or, if upregulated, to be detected using the technique of Western Rats in Grouo 1 were infused chronicallv with caotouril (20 &ku/min) for 14 days. Rats In Group 2 were infused chronrcally wrth captopril fo; 74 days and Ang II (5 ng/kg/min) was given for the last 10 days Glomerular filtration rate (GFR) and renal plasma flow (RPF) were measured at days 4 and 14 of the infusions Data are expressed as mean?SEM and drffereJces between groups were analyzed by ANOVA blot. These data suggest that it is unlikely that the increase in NOS III synthesis plays an important role in the acute ANGII-NO interaction. However, the fact that NOS III mRNA is increased suggests an important initiating step in the interaction between NO and ANGII which goes beyond the transient acute interactions.
In support of the latter hypothesis, chronic ANGII infusion for 10 days increased mean arterial pressure and tended to reduce GFR and renal plasma flow. Chronic ANGII infusion had no effect on renal NOS 111 mRNA levels. However, renal NOS III protein levels were increased significantly with ANGII. This pattern of increased protein in the absence of increases in mRNA is consistent with an increase in basal production of NOS III enzyme, perhaps due to stabilization of the message, thus not requiring an increase in mRNA to increase translation of the protein. Barring any change in L-arginine substrate or NO synthase cofactors, the increase in NOS III protein would cause increased production of NO in the kidney. These data suggest then that ANGII can stimulate renal NO production by increasing NOS III protein content. Consistent with our findings is a preliminary report by Zou and colleagues, who found the ANGII directly increases NO
